An ICMR study reveals Kerala’s low hepatitis A seroprevalence (44.8%) compared to South India’s intermediate rates (74.8%-83.1%). The study highlights India’s epidemiological transition, urging state-specific vaccination policies. Kerala’s low endemicity necessitates outbreak preparedness, while cost-effective vaccination could address rising acute liver infections.